Seed Wealth Management’s Edwards Lifesciences EW Stock Holding History

Seed Wealth Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,120	Closed	-$244K	–	127
2025 Q2	$244K	Hold	3,120	–	–	0.18%	126
2025 Q1	$226K	Hold	3,120	–	–	0.18%	135
2024 Q4	$231K	Hold	3,120	–	–	0.19%	131
2024 Q3	$206K	Hold	3,120	–	–	0.16%	149
2024 Q2	$288K	Hold	3,120	–	–	0.25%	101
2024 Q1	$294K	Hold	3,120	–	–	0.28%	91
2023 Q4	$236K	Hold	3,120	–	–	0.24%	118
2023 Q3	$216K	Hold	3,120	–	–	0.24%	122
2023 Q2	$294K	Hold	3,120	–	–	0.31%	82
2023 Q1	$258K	Hold	3,120	–	–	0.29%	88
2022 Q4	$233K	Buy	+3,120	New	+$240K	0.27%	98

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Seed Wealth Management's EW Position: Q3 2025 in Review

Seed Wealth Management sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 3,120 shares — an estimated $244K sold.

Seed Wealth Management first reported a position in EW in Q4 2022 and held it in 11 quarters. The position peaked at $294K in Q2 2023. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Seed Wealth Management reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
Seed Wealth Management sold 3,120 Edwards Lifesciences shares in Q3 2025, an estimated $244K.
Seed Wealth Management first reported a position in Edwards Lifesciences in Q4 2022 and held it in 11 quarters.
Seed Wealth Management's Edwards Lifesciences position peaked at $294K in Q2 2023.
1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Seed Wealth Management's 13F filing for Q3 2025, filed 15 Oct 2025.